✦ LIBER ✦

Late stage treatment with arimoclomol delays disease progression and prevents protein aggregation in the SOD1G93A mouse model of ALS

✍ Scribed by Bernadett Kalmar; Sergey Novoselov; Anna Gray; Michael E. Cheetham; Boris Margulis; Linda Greensmith

Book ID: 111181056
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 688 KB
Volume: 107
Category: Article
ISSN: 0022-3042
DOI: 10.1111/j.1471-4159.2008.05595.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antisense peptide nucleic acid targeting

Antisense peptide nucleic acid targeting GluR3 delays disease onset and progression in the SOD1 G93A mouse model of familial ALS

✍ Alan Rembach; Bradley J. Turner; Stephen Bruce; Irwin K. Cheah; Rachel L. Scott; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB

## Abstract Glutamate excitotoxicity is strongly implicated as a major contributing factor in motor neuron degeneration in amyotrophic lateral sclerosis (ALS). Excitotoxicity results from elevated intracellular calcium ion (Ca^2+^) levels, which in turn recruit cell death signaling pathways. Recent

Vacuolization correlates with spin–spin

Vacuolization correlates with spin–spin relaxation time in motor brainstem nuclei and behavioural tests in the transgenic G93A-SOD1 mouse model of ALS

✍ Selina Bucher; Kerstin E. Braunstein; Heiko G. Niessen; Thomas Kaulisch; Michael 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB